Clinical therapies developed for estrogen-deficiency-driven postmenopausal osteoporosis
(PMO) and related diseases, such as bone degeneration, show multiple adverse effects …

Anti-resorptive and anabolic agents are often prescribed for the treatment of osteoporosis
continuously or sequentially for many years. However their impact on cortical bone quality …

Osteoporosis, a metabolic bone disease, threatens postmenopausal women globally.
Hormone replacement therapy (HTR), especially estrogen replacement therapy (ERT), is …

Objective Formononetin (Formo) prevents ovariectomy (Ovx)-induced bone loss in rats.
However, there are no reports on the curative effects of Formo. The objective of this study …

Objectives The aim of this study was to investigate bone turnover alterations after
alendronate (ALD) withdrawal and its influence on dental implants osseointegration …

Estrogen deprivation accelerates bone resorption, leading to imbalance of bone remodeling
and osteoporosis in postmenopausal women. In the elderly, type 2 diabetes mellitus (T2DM) …

Bisphosphonates are being increasingly used to treat pediatric patients with skeletal
disorders. However, the effects of long‐term bisphosphonate therapy and cessation of …

The aims of this study were to evaluate the osteoprotective effect of aqueous extract from
Rhizoma Dioscoreae (RDE) on rats with ovariectomy‐(OVX‐) induced osteopenia. Our …

ETHNOPHARMACOLOGICAL RELEVANCE: Hachimi-jio-gan is one of the most common
recipes in traditional Chinese, Japanese and Korean medicines and has been used for …

In assessing the relationship between calcium supplementation and maintaining bone mass
or reducing the risk of fracture, the effectiveness of calcium supplementation has never been …